BPC 157 in the cytoprotection tradition of Robert
doi: 10.1002/cbdv.202000171 355 AdamczakAOarowskiMKarpiskiTM
Based on current approval in the United States and prescribing criteria for treatments such as Wegovy and Mounjaro, eligibility in the UK would likely be similar and include adults with: a BMI of 30 or above (obesity), or a BMI of 27 or above with at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or abnormal cholesterol levels Final eligibility will depend on how the medicine is licensed in the UK
Even when they do, the repaired tissue is often biomechanically inferior, with a high scar component
Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G, Substance P